A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. - Wikidata - wikimedia - TriplyDB

A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction.

A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction.

http://www.wikidata.org/entity/Q37438098

about

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders Genetics of Parkinson's disease Genetically engineered mouse models of Parkinson's disease Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance Alpha-synuclein spreading in Parkinson's disease The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.The Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson's Disease Owing Genetic and Anatomical Specificity.Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death.G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease.α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?Genetic insights into sporadic Parkinson's disease pathogenesis.Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.A new role for α-synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication.α-Synuclein and Parkinsonism: Updates and Future Perspectives.Cognitive decline in Parkinson disease.Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins.From the baker to the bedside: yeast models of Parkinson's disease.αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease.Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study.Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.

P2860

Q22252904-AB190078-045B-402E-BE99-9F48DF1672C9 Q26744716-7FE96266-6B39-48D9-A809-CBCDA29FE385 Q26800286-EB567C7A-4A00-4BA5-85E9-ABFE8A5FAC21 Q26827825-EB95CDD2-CE41-457D-9F31-81D7A2837723 Q26852964-DC87430F-EEC5-4370-927E-8556C02CEA6D Q28077356-C2ABAE97-27F5-457B-BA2F-C089AA6BE51F Q28082548-734A3404-FF6E-43A4-8CA7-F05E0BCA9F06 Q30249098-0C5ED67C-E766-4F52-8389-9C25D5118E13 Q30357944-563F2B7F-7A3E-4189-81BC-1FB29AA820E9 Q30493972-7DF4C83D-8103-4D62-B0C5-4DCFC00D95F6 Q34043163-032C59DC-F9AE-449A-A9CE-2520AC597E52 Q34335126-46AA4868-8597-4DE7-9AB6-FFD2B3BC2E60 Q35351512-C010B443-A76F-4C55-9CB2-DEB3E0D5E7FC Q36251993-54EF2F58-81F1-4F43-89C6-6B3D2089C21F Q36925651-296C02A4-CCC8-443C-B5B0-CCDA44C52406 Q37583402-34D0B078-6B7F-47B3-8C35-5E26280AFD28 Q38038126-1F4F8928-8A6D-4153-9CF4-046DFC32B6A4 Q38465664-ABFEFEAF-4331-4B50-A277-B97CEF91C9C5 Q38742153-69E9A40D-1B07-4779-BD17-4C0CCFD5CD7B Q38751099-70E42CEB-669C-4EC7-9A35-E7809F302A2D Q38822626-EFE25689-70EA-45DC-B2E1-70A71EF03FFA Q39208122-F5AD2E9D-0C5D-4BC7-A15E-C45E77803419 Q40986110-F4DCBB29-E537-4ED5-8B86-2B0D9E8435FA Q41664833-DDD5ABD4-C349-454C-BFB3-6FB8DF404E47 Q47872914-D82C4296-75FA-471E-87BC-522BB3B40AE4 Q48175839-C7A12C05-CA96-4647-8073-0128B40FD1EE Q53397478-13BBB777-B661-4555-BB9E-4D0BF1E9C505

P2860

A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction.

http://www.wikidata.org/entity/Q37438098

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A Swedish family with de novo ...... or early cortical dysfunction.

@en

A Swedish family with de novo ...... or early cortical dysfunction.

@nl

type

label

A Swedish family with de novo ...... or early cortical dysfunction.

@en

A Swedish family with de novo ...... or early cortical dysfunction.

@nl

altLabel

A Swedish family with de novo ...... for early cortical dysfunction

@en

prefLabel

A Swedish family with de novo ...... or early cortical dysfunction.

@en

A Swedish family with de novo ...... or early cortical dysfunction.

@nl

P1433

Q37438098-D13103FF-4545-4BBF-A8E6-65A189303AE6

P1476

Q37438098-6D13B467-C8D3-4B33-8784-228340DAE676

P2093

Q37438098-10D12CD8-8689-4043-8D43-63F5C3AEFFC2

Q37438098-25088CB7-9BDF-4B33-87E3-2E7BD260E7FF

Q37438098-4D5613BC-2FE4-458D-B230-C8D7D8EB2296

Q37438098-51001DBA-BAD7-40C2-A4EB-DE381B110D44

Q37438098-82BD054C-9AD2-4452-9C93-9BF7E1F7CD74

Q37438098-9C826D71-B8A4-4AB6-A35E-AA72CDF389C8

Q37438098-ACA92B02-ED02-4B1E-A41F-DFCADA360869

Q37438098-AD9E43B2-9913-4199-8307-31588B647420

Q37438098-BDBBE552-0E02-4A25-B891-37795542B536

Q37438098-C418ED50-091F-4A30-AC49-F7AA244CF2AC

P2860

Q37438098-0D7738DB-C8A1-4686-BDE0-6FDA9231B8BA

Q37438098-16DB8D96-30BF-481F-87D1-30A39BC0C70E

Q37438098-213D9D5A-02C5-4165-84BC-80B22A30273D

Q37438098-2B17A334-CD19-4535-BD8B-4D37A4FA7769

Q37438098-2E256EC0-CF2E-4515-8336-13BDA0B20807

Q37438098-5FA4F4B8-8C18-4854-85A0-0143CDB93686

Q37438098-64BC932D-D96E-4754-AB6C-21B866F6DA2A

Q37438098-65DC02D6-229C-4719-A3C9-DB8967BFE6B4

Q37438098-6CF3D6B7-C261-40B2-AEC3-687AD711BAB6

Q37438098-8D06F68B-C1C1-47E2-B7A8-82A127E162F6

P304

Q37438098-9B2D974D-F957-4FEB-B280-49C6A5479187

P31

Q37438098-234FF538-3FBB-4BD8-975F-3E716D8B1447

P356

Q37438098-EC556985-B87B-4A09-89B6-511D92D0520E

P433

Q37438098-214EAEAB-0795-4243-A1AB-367BE21C987A

P478

Q37438098-1F4ACDE9-5DC0-4774-85A7-2AE7CFA9B949

P50

Q37438098-07A45D9C-640E-40E7-8963-7A91271D19C8

Q37438098-1A8E4542-E0C3-4884-A324-BA454D536DD5

Q37438098-C3171B62-5E1A-4373-8322-48E949B496F0

Q37438098-DC845D86-429A-4669-B9D7-2D87E6C18DE3

Q37438098-F976CCE2-997C-42CD-95A4-7279F91457F5

P577

Q37438098-94A88501-9FBB-4B9A-84FE-49898399CF2F

P5875

Q37438098-22B307B9-3480-4534-98A4-EB5E868E1EAE

P698

Q37438098-910DD79B-191D-4083-B6A9-A57A3DBD6E32

P921

Q37438098-1A14E59C-8392-47E3-8177-5CE0DFCE0C93

Q37438098-B1459D58-E8CA-4351-8277-B3E35F306AE8

P932

Q37438098-2C4F0CE9-CD35-47C0-95FC-3BE04988A2FB

P356

J.PARKRELDIS.2009.06.007

P1433

Parkinsonism and Related Disorders

P1476

A Swedish family with de novo ...... or early cortical dysfunction.

@en

P2093

Bruce A Chase

http://www.w3.org/2001/XMLSchema#string

Christer Nilsson

http://www.w3.org/2001/XMLSchema#string

Danielle van Westen

http://www.w3.org/2001/XMLSchema#string

Douglas Hägerström

http://www.w3.org/2001/XMLSchema#string

Håkan Widner

http://www.w3.org/2001/XMLSchema#string

Jan Reimer

http://www.w3.org/2001/XMLSchema#string

Jennifer M Kachergus

http://www.w3.org/2001/XMLSchema#string

Jørgen E Nielsen

http://www.w3.org/2001/XMLSchema#string

Karin Nilsson

http://www.w3.org/2001/XMLSchema#string

Katerina Markopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

A large kindred with autosomal dominant Parkinson's disease

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.

Diagnostic criteria for Parkinson disease.

Criteria for diagnosing Parkinson's disease.

Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.

Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.

A case of late onset sporadic Parkinson's disease with an A53T mutation in alpha-synuclein.

Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.

Clinical characteristics of the alpha-synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece.

P304

627-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PARKRELDIS.2009.06.007

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Carles Vilariño-Güell

Matthew J. Farrer

Andreas Puschmann

Zbigniew K Wszolek

P577

2009-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26695989

http://www.w3.org/2001/XMLSchema#string

P698

19632874

http://www.w3.org/2001/XMLSchema#string

P921

P932

2783246

http://www.w3.org/2001/XMLSchema#string